¥

News & Events

News, Events & Presentations

Overview

Corporate Profile

Castle Creek Biosciences, Inc., a late-stage cell and gene therapy company, is using lentiviral vector delivery platforms to develop and commercialize gene therapies, initially targeting skin, connective tissue and metabolic diseases. Our scientists use ex vivo and in vivo technologies to switch gene targets and create optimal therapies for a multitude of genetic diseases.

Investors



 

Castle Creek Biosciences News

July 22, 2020

News, Events & Presentations

Read More